16.14BMarket Cap
35.15P/E TTM
ASND Balance Sheet
You can check out the annual or quarterly balance sheets of Ascendis Pharma A/S here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing ASND stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Ascendis Pharma A/S Have?
In its most recent quarterly, Ascendis Pharma A/S had 671.63M in cash and cash equivalents.
How Much Are Ascendis Pharma A/S's Total Liabilities?
Ascendis Pharma A/S reported 1.74B in total liabilities as of the latest reported quarter, including 1.27B in current liabilities and 470.05M in non-current liabilities.
What Are Ascendis Pharma A/S's Total Assets?
As of the latest reported quarter, Ascendis Pharma A/S's total assets were 1.55B, consisting of 1.32B in current assets and 229.79M in non-current assets.
How Much Shareholders' Equity Does Ascendis Pharma A/S Have?
Ascendis Pharma A/S reported -193.27M in total shareholders' equity as of the latest reported quarter.